or Try an Advanced Search...

    Treatment Of Cancer Stocks List

    Symbol Grade Name % Change
    GTHX A G1 Therapeutics, Inc. 0.00
    TGTX B TG Therapeutics, Inc. 10.45
    EXEL B Exelixis, Inc. 0.38
    ACTU C Actuate Therapeutics, Inc. 3.29
    RNA C Avidity Biosciences, Inc. -0.34
    NRIX C Nurix Therapeutics, Inc. 0.44
    ELTX C Elicio Therapeutics, Inc. 0.00
    CERO C CERo Therapeutics Holdings, Inc. 10.41
    INAB D IN8bio, Inc. 5.35
    ELEV D Elevation Oncology, Inc. 2.70
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Life Sciences Lymphoma Solid Tumors Cell Therapy Clinical Medicine Disease Hematological Malignancies Monoclonal Antibody Pharmaceutical Products Protein Kinase Inhibitor Small Molecule Therapies Tyrosine Kinase Acute Leukemia Adoptive Cell Transfer Advanced Solid Tumors Aging Associated Diseases Anaplastic Lymphoma Kinase

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cancer stocks.

    Symbol Grade Name Weight
    IDNA D iShares Genomics Immunology and Healthcare ETF 8.13
    PBE D PowerShares Dynamic Biotech & Genome 7.64
    BBP C BioShares Biotechnology Products Fund 5.16
    SURI C Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 5.13
    FBT D First Trust Amex Biotech Index Fund 4.51
    View all Treatment Of Cancer ETFs...
    Compare ETFs
    Compare BBP to FBT Compare IDNA to BBP Compare SURI to FBT

        Treatment Of Cancer Stocks Recent News

        Date Stock Title
        Nov 21 TGTX TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 20 EXEL Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
        Nov 17 NRIX Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
        Nov 15 CERO CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
        Nov 14 RNA Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
        Nov 14 ELTX Elicio Therapeutics GAAP EPS of -$1.39
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
        Related Stock Lists: Cancer Biopharmaceutical Biotechnology Life Sciences Lymphoma Solid Tumors Cell Therapy Clinical Medicine Disease Hematological Malignancies Monoclonal Antibody Pharmaceutical Products Protein Kinase Inhibitor Small Molecule Therapies Tyrosine Kinase Acute Leukemia Adoptive Cell Transfer Advanced Solid Tumors Aging Associated Diseases Anaplastic Lymphoma Kinase
        Treatment Of Cancer

        Treatment of cancer depends on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and/or hormone therapy. In some cases, a combination of treatments may be used.

        Browse All Tags